Close
advertisement
advertisement

Learn About
Types of Arthritis

See More Types

Stay Connected

btn-sc-social-community btn-sc-social-facebook btn-sc-social-twitter btn-sc-social-youtube btn-sc-social-newsletters

Newsletters

widg-newsletter-laptop

Get the practical information you need to live better with arthritis delivered straight to your inbox!

Arthritis Today

How to reduce pain, find the right treatments and live better with arthritis. [Bi-weekly]

Fitness + Nutrition

Get weight-loss tips, arthritis-friendly recipes and ways to exercise safely. [Bi-weekly]

Mind, Body, Spirit

Find arthritis care tips, inspirational stories and Arthritis Foundation news. [Monthly]

RA Insider

Beyond the basics of rheumatoid arthritis: research, news and treatment. [Monthly]

sign up

FDA Advisory Panel Recommends Approval of New RA Drug

Tofacitinib is part of an up-and-coming new class of disease-modifying drugs called JAK inhibitors.

05/10/2012 | By Jennifer Davis


comments powered by Disqus

FDA Advisory Panel Recommends Approval of New RA Drug

Tofacitinib is part of an up-and-coming new class of disease-modifying drugs called JAK inhibitors.

05/10/2012 | By Jennifer Davis


comments powered by Disqus
advertisement
 
Advertisement